SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Significant Drop in Short Interest

SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Rating) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 138,200 shares, a decline of 30.1% from the March 15th total of 197,800 shares. Currently, 0.4% of the company’s shares are short sold. Based […]

Related Keywords

, Silver Oak Securities Incorporated , Hightower Advisors , Biotherapeutics Company Profile , Sab Biotherapeutics Inc , Millennium Management , Citadel Advisors , Nasdaq , Biotherapeutics Inc , Get Rating , Street Corp , Oak Securities Incorporated , Sab Biotherapeutics , Nasdaq Sabs , Sabs , Medical , Stocks , Options , Put , Call ,